Evaxion AS (EVAX)
2.74
-0.03
(-1.08%)
USD |
NASDAQ |
Nov 13, 16:00
2.75
+0.01
(+0.36%)
Pre-Market: 19:59
Evaxion Enterprise Value : 15.96M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 15.96M |
| November 12, 2026 | 16.21M |
| November 11, 2026 | 17.38M |
| November 10, 2026 | 16.96M |
| November 09, 2026 | 16.04M |
| November 06, 2026 | 18.13M |
| November 05, 2026 | 16.12M |
| November 04, 2026 | 17.88M |
| November 03, 2026 | 17.79M |
| November 02, 2026 | 17.46M |
| October 30, 2026 | 17.54M |
| October 29, 2026 | 18.79M |
| October 28, 2026 | 19.04M |
| October 27, 2026 | 18.46M |
| October 26, 2026 | 18.79M |
| October 23, 2026 | 24.46M |
| October 22, 2026 | 24.05M |
| October 21, 2026 | 24.05M |
| October 20, 2026 | 26.88M |
| October 19, 2026 | 20.88M |
| October 16, 2026 | 16.71M |
| October 15, 2026 | 16.46M |
| October 14, 2026 | 16.46M |
| October 13, 2026 | 16.12M |
| October 12, 2026 | 18.13M |
| Date | Value |
|---|---|
| October 09, 2026 | 18.71M |
| October 08, 2026 | 18.54M |
| October 07, 2026 | 19.46M |
| October 06, 2026 | 19.46M |
| October 05, 2026 | 19.38M |
| October 02, 2026 | 19.79M |
| October 01, 2026 | 19.63M |
| September 30, 2026 | 20.46M |
| September 29, 2026 | 20.38M |
| September 28, 2026 | 20.13M |
| September 25, 2026 | 20.96M |
| September 24, 2026 | 20.29M |
| September 23, 2026 | 20.46M |
| September 22, 2026 | 20.38M |
| September 21, 2026 | 19.88M |
| September 18, 2026 | 20.38M |
| September 17, 2026 | 19.96M |
| September 16, 2026 | 18.38M |
| September 15, 2026 | 18.46M |
| September 14, 2026 | 18.71M |
| September 11, 2026 | 19.21M |
| September 10, 2026 | 18.96M |
| September 09, 2026 | 20.54M |
| September 08, 2026 | 19.54M |
| September 04, 2026 | 19.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Autolus Therapeutics Plc | 502.92M |
| DBV Technologies SA | 548.69M |
| Cellectis SA | 56.26M |
| Akari Therapeutics Plc | 9.736M |
| Bicycle Therapeutics Plc | -284.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.724M |
| Total Expenses (Quarterly) | 3.724M |
| EPS Diluted (Quarterly) | -0.4464 |
| Earnings Yield | -38.45% |
| Normalized Earnings Yield | -38.63 |